Biome Australia Limited

BIO.ASX

Consumer Staples

Licencing, development and marketing of complimentary medicines, including nutraceuticals and live biotheraputics.

Market Data

Price

$0.230

-0.0%
Market Cap

$54.7M

P/E Ratio

57.1x

EPS

$0.004

Div. Yield

0.00%

52-Week Change

-0.5%

Latest Earnings

Appendix 4D & Half Yearly Report

23 February 2026

Revenue
$12.40
+39.9% YoY
NPAT
$1.18
+171.5% YoY
EPS
$0.01

Biome Australia delivered strong half-year results with revenue up 39.9% to $12.4M and net profit surging 171.5% to $1.18M, driven by continued momentum in their Activated Probiotics and new Activated Therapeutics ranges. The company generated positive operating cash flow of $2.09M (vs $1.12M outflow prior year) and achieved eight consecutive quarters of positive EBITDA, while expanding internationally across Canada, Ireland, UK and New Zealand. Key points: Revenue growth of 39.9% to $12.4M driven by Activated Probiotics and new Activated Therapeutics ranges; Net profit increased 171.5% to $1.18M with strong operational performance; Positive operating cash flow turnaround of $3.21M from $1.12M outflow to $2.09M inflow

Recent Announcements

23 Feb 2026 Actual Results Positive

Appendix 4D & Half Yearly Report

Biome Australia delivered strong half-year results with revenue up 39.9% to $12.4M and net profit surging 171.5% to $1.18M, driven by continued momentum in their Activated Probiotics and new Activated Therapeutics ranges. The company generated positive operating cash flow of $2.09M (vs $1.12M outflow prior year) and achieved eight consecutive quarters of positive EBITDA, while expanding internationally across Canada, Ireland, UK and New Zealand. Key points: Revenue growth of 39.9% to $12.4M driven by Activated Probiotics and new Activated Therapeutics ranges; Net profit increased 171.5% to $1.18M with strong operational performance; Positive operating cash flow turnaround of $3.21M from $1.12M outflow to $2.09M inflow

18 Feb 2026 Supplementary Neutral

Biome Half Year Results and Webinar

This is an announcement that Biome Australia will release their H1 FY26 financial results on February 23, 2026, followed by an investor webinar on February 25. No actual financial results or performance metrics are disclosed in this pre-announcement. Key points: Results release scheduled for February 23, 2026; Live investor webinar with Q&A session planned for February 25; Will include progress update on Vision 27 strategic plan

Get real-time alerts for BIO

Receive AI-powered earnings summaries and instant notifications when Biome Australia Limited releases results.

Register Free